Results, filtered by:
157 {0} - {1} of {2} items
GSK UK Products
This site provides information on GSK medicines and vaccines for members of the UK public, patients and their carers.
Mivacron
Mivacron (mivacurium chloride) links to the summary of product characteristics and patient information leaflet to support UK patients and carers when prescribed.
Ambirix product overview
Ambirix product information to support UK patients and carers when prescribed.
Report suspected side effect
Form for UK members of the public and patients that have been prescribed a GSK medicine or vaccine to report a suspected side effect
Haleraid | GSK public
Haleraid is a device developed to help patients with impaired hand agility administer a range of GSK inhalers.
Ellipta – About the Ellipta device | GSK Pharma UK | Public site
A product overview of the Ellipta device for members of the public or for patients prescribed an Ellipta medicine in the UK.
▼ JEMPERLI (dostarlimab) | GSK public UK
▼JEMPERLI (dostarlimab) information for UK members of the public.
Twinrix
Information on Twinrix vaccine for members of public including summary of product characteristics and patient information leaflet
Menveo
Information on Menveo vaccine for members of public including summary of product characteristics and patient information leaflet
Twinrix Paediatrics
Information on Twinrix Paediatrics vaccine for members of public including summary of product characteristics and patient information leaflet
Ambirix
Information on Ambirix vaccine for members of public including summary of product characteristics and patient information leaflet
Fendrix
Information on Fendrix vaccine for members of public including summary of product characteristics and patient information leaflet
Bexsero overview
Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet.
Havrix Monodose
Information on Havrix Monodose vaccine for members of public including summary of product characteristics and patient information leaflet
Nucala (mepolizumab) for patients - GSK Pharma UK
This page is specifically for patients who have been prescribed Nucala (mepolizumab) and can help to provide you with further information on your Nucala medication.
Blenrep▼ (belantamab mafodotin) | GSK public UK
Blenrep▼ (belantamab mafodotin) | Information for members of the public
Zejula (niraparib)
Information for members of public on Zejula (niraparib)
Contact us
GSK UK contact us page for members of the UK public
Blenrep ▼ (belantamab mafodotin) – I am on Blenrep ▼ (belantamab mafodotin) in combination with pomalidomide and dexamethasone
Information on how Blenrep ▼ (belantamab mafodotin) in combination with pomalidomide and dexamethasone if given and potential side effects
Blenrep ▼ (belantamab mafodotin) – Things to tell your doctor
Things to tell your doctor before and during your Blenrep treatment
Blenrep ▼ (belantamab mafodotin) – I am on Blenrep ▼ (belantamab mafodotin) in combination with bortezomib and dexamethasone
Information on how Blenrep ▼ (belantamab mafodotin) in combination with bortezomib and dexamethasone if given and potential side effects
Blenrep▼ (belantamab mafodotin) – Frequently asked questions and Resources
Practical information, including FAQs and Resources, for patients who have been prescribed Blenrep
Blenrep ▼ (belantamab mafodotin) – Understanding how Blenrep works
Information on how Blenrep ▼ (belantamab mafodotin) works for patients who have been prescribed Blenrep
BLENREP ▼ (belantamab mafodotin) – I am a patient
Information on BLENREP ▼ (belantamab mafodotin) for patients who have been prescribed Blenrep, including dosing and side effects
I am a patient
Information about how to use the Ellipta device for UK patients who have been prescribed a medicine to be taken via Ellipta.
GSK Public Patient Website – Trelegy Ellipta
A page within the ‘I am a patient’ section of the website, this will be where patients who have just been prescribed trelegy, can find out more about their patient support packs. Additionally, they can download digital versions of the symptom tracker and action planner.
Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) | GSK Public UK
Information on Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) for members of public including summary of product characteristics and patient information leaflet
Engerix B Paediatrics (hepatitis B (rDNA) vaccine adsorbed (HBV))
Information on Engerix B Paediatrics vaccine for members of public including summary of product characteristics and patient information leaflet
Havrix Junior Monodose
Information on Havrix Junior Monodose vaccine for members of public including summary of product characteristics and patient information leaflet
Bexsero
Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet.
Engerix B
Information on Engerix B vaccine for members of public including summary of product characteristics and patient information leaflet
Dectova ▼ (zanamivir hydrate) | GSK Public UK
Information on Dectova▼(zanamivir hydrate) for members of public including summary of product characteristics and patient information leaflet
AREXVY ▼
AREXVY patient information for members of the UK public
Products | GSK public UK
GSK product information for UK members of the public and patients
Infanrix-IPV+Hib (Diptheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine adsorbed)) | GSK Public UK
Information on Infanrix-IPV+Hib (Diptheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine adsorbed)) for members of public including summary of product characteristics and patient information leaflet
Menitorix (hib, meningococcal group c combined vaccine) | GSK Public UK
Information on Menitorix (hib, meningococcal group c combined vaccine) for members of public including summary of product characteristics and patient information leaflet
Varilrix (live attenuated varicella-zoster (Oka strain) virus) | GSK Public UK
Information on Varilrix (live attenuated varicella-zoster (Oka strain) virus) for members of public including summary of product characteristics and patient information leaflet
Ventolin Inhalers (salbutamol) SmPC and Patient Information Leaflet
Summary of Product Characteristics (SmPC) and PIL for Ventolin inhalers containing salbutamol.
Priorix (Measles, Mumps and Rubella vaccine (live)) | GSK Public UK
Information on Priorix (Measles, Mumps and Rubella vaccine (live)) for members of public including summary of product characteristics and patient information leaflet
Rotarix (live attenuated rotavirus vaccine) | GSK Public UK
Information on Rotarix (live attenuated rotavirus vaccine) for members of public including summary of product characteristics and patient information leaflet
Relvar Ellipta Inhalers
Information on Relvar Ellipta for members of public including summary of product characteristics and patient information leaflet
Relenza (zanamivir) | GSK Public UK
Information on Relenza (zanamivir) for members of public including summary of product characteristics and patient information leaflet
MOP | SHINGRIX landing page
SHINGRIX patient information for members of the UK public
NUCALA (mepolizumab) Overview
Member of Public Page | Nucala (mepolizumab) Overview.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – My Medicine
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – I am a patient
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Including how to use the device and side effects.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – Possible side effects
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Information about the possible side effects.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) product information for the UK members of the public
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – FAQs
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Frequently asked questions.
Show more
▼ - This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the Patient information leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store.
By reporting side effects you can help provide more information on the safety of this medicine.
